Journal article

A randomised, double-blind, placebo-controlled phase 2 study of trebananib (AMG 386) in combination with FOLFIRI in patients with previously treated metastatic colorectal carcinoma

M Peeters, AH Strickland, M Lichinitser, AVS Suresh, G Manikhas, J Shapiro, W Rogowski, X Huang, B Wu, D Warner, R Jain, NC Tebbutt

British Journal of Cancer | NATURE PUBLISHING GROUP | Published : 2013